Study Evaluating the Efficacy of the myDIET Software Tool in the Nutritional Management of Patients With Localized and Resectable Gastric or Esogastric Junction Cancer.
Trial Parameters
Brief Summary
This is a prospective, single-center, single-arm Phase II study evaluating the efficacy of the myDIET software tool in the nutritional management of patients with localized and resectable esogastric junction cancer.
Eligibility Criteria
Inclusion Criteria: * Patient 18 years of age or older at date of signing informed consent to participate; * Histologically proven diagnosis of gastric adenocarcinoma or OGJ; * Localized, resectable disease; * Patient treated with perioperative Oxaliplatin-based chemotherapy, * Performance status (ECOG): 0-2; * Membership of a social security scheme; * Signed informed consent to participate. Exclusion Criteria: * Other associated solid cancer or haemopathy; * Presence of severe comorbidity (Charlson index \< 9) * Presence of unbalanced dysthyroidism (TSH not within laboratory norm at inclusion, usually between 0.4 and 4 mUI/L); * History of gastric, duodenal or esophageal surgery; * Inability to comply with study requirements, including : * Impossibility for the patient or his/her caregiver to connect to myDIET; * Difficulty in understanding the written French language; * Psychological incapacity (e.g. excessive vulnerability, psychiatric disorder) or physical incapacity (e.g. physical